Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Terms of Use
Privacy Policy
Sitemap
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Hemophilia
Do you incorporate DVT prophylaxis after joint arthroscopy in a patient with hemophilia?
If so, what is your preferred agent?
Related Questions
In patients with severe hemophilia A on emicizumab for prophylaxis, in case of noncompliance leading to a lapse of more than 2-3 months off therapy, do you reload with emicizumab?
Would you discontinue anticoagulation in patients with antiphospholipid antibody syndrome, who have a remote history of thrombotic events and are now negative for pathogenic antiphospholipid antibodies?
How do you manage patients who develop minor antigen antibodies and require multiple blood transfusions?
How do you diagnose sickle hepatopathy?
Would you check vitamin B6 routinely in the work up of anemia?
In massive transfusion protocol from suspected hemorrhage, is it worth obtaining a TEG to guide transfusion?
Would you anticoagulate recurrent venous thromboembolism in a patient with Ehlers Danlos syndrome?
How soon do you anticipate response to cyclosporine in red cell aplasia and what cyclosporine trough levels do you target?
Do you hold IV iron in the setting of active infection?
When do you consider plasma exchange for multiorgan failure in a patient with sickle cell disease?
